Richard Crowley is SVP & Biopharmaceutical Ops at IMCLONE SYSTEMS INC (IMCL). They have made 2 open-market trades across 1 company since 2006, most recently 2013-10-15.
CIK 0001352961
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $8K since 2011, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SVNT | SELL | 2013-10-15 | 2013-10-17 | $0.08 | $9K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2013-04-30 | 2013-05-01 | $0.74 | $2K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2013-02-04 | 2013-02-06 | $1.03 | $51K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2013-01-31 | 2013-02-04 | $1.02 | $2K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2012-10-31 | 2012-11-06 | $1.45 | $3K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2012-08-02 | 2012-08-03 | $0.62 | $2K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2012-05-01 | 2012-05-01 | $2.35 | $22K | N/A | N/A | N/A |
| SVNT | BUY | 2011-11-21 | 2011-11-22 | $2.53 | $8K | N/A | N/A | N/A |
| IMCL | SELL · 10b5-1 | 2008-11-03 | 2008-11-07 | $68.72 | $822K | N/A | N/A | N/A |
| IMCL | SELL · 10b5-1 | 2008-09-02 | 2008-09-04 | $64.40 | $770K | N/A | N/A | N/A |
| IMCL | SELL · 10b5-1 | 2007-11-19 | 2008-08-01 | $64.16 | $1.7M | N/A | N/A | N/A |
| IMCL | SELL · 10b5-1 | 2007-11-19 | 2007-11-21 | $42.65 | $390K | N/A | N/A | N/A |
| IMCL | SELL · 10b5-1 | 2006-07-03 | 2006-07-05 | $38.68 | $39K | N/A | N/A | N/A |
| IMCL | SELL · 10b5-1 | 2006-06-01 | 2006-06-05 | $39.84 | $40K | N/A | N/A | N/A |
| IMCL | SELL · 10b5-1 | 2006-05-01 | 2006-05-03 | $35.96 | $36K | N/A | N/A | N/A |
| IMCL | SELL · 10b5-1 | 2006-04-21 | 2006-04-24 | $35.00 | $35K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.